26-08-2026 11:49 via pharmacypracticenews.com

Safety Groups Sound Alarm After FDA Compounding Panel Backs 6 of 7 Peptides

Originally published by our sister publication Specialty Pharmacy Continuumfigure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%; height:auto; width:auto; display:block; }figcaption { padding:5px; background:transparent; word-wrap:normal; text-align:center; font-size:10px; line-height:12px; }.figure-wrapper { text-align:center; }Atrom, Piya W. - Stock.adobe.com.By Gina ShawThe FDA Pharmacy Compounding
Read more »

Pharmacy news



Safety Gains in Parenteral Nutrition, but Prescribing Gaps Persist
FDA Approves Daraxonrasib for Metastatic Pancreatic Cancer
2 Measles-Associated Deaths in Pennsylvania
Student Pharmacy Phone Calls Boost Cancer Pain Management
New Consensus Recs For Tardive Dyskinesia Focus on Long-Term Rx
New Phase 3 Data Show BEM/RZR Noninferior to Epclusa for Hep C
Managing IBD Patients With Few Options Left
5-Year POSITIVE Data Reassure on Pregnancy in Breast Cancer
Rethinking Iron Deficiency Anemia
Clinical Competence Is the Cornerstone of Ig Outcomes
The Value of the ACHC/IgNS Distinction in Immunoglobulin Therapy
Are We on Shaky Ground With Medication Adherence?
Targeting CD4 to Treat HIV
An Oklahoma Health System’s Road to Dual-Specialty Pharmacy Accreditation
Desktop versie